Perrigo Co PLC

Insider buying at €10.72 shows Perrigo’s executives see a turnaround, boosting confidence in its OTC and generic drug strategy. Explore the outlook and risks.

Insider trading at Perrigo Co PLC shows CEO Lockwood‑Taylor buying on a low €8.86 price, indicating confidence in the stock’s undervaluation and potential rebound.

Investor insight: CFO Guarita’s mixed buying and selling at Perrigo signals confidence yet strategic balance, highlighting insider moves that could spark a cautious rally.